Fact Source: Financial Supervisory Service DART / 2025-07-14
Disclosure Type: Setting of Shareholder Register Closing Period or Record Date
💡 3-Second Summary
Samsung Biologics has officially announced that it has designated July 29, 2025, as the shareholder record date to finalize the list of eligible voters for its upcoming Extraordinary General Meeting of Shareholders.
📊 1. [Key Disclosure Content & Summary of Financial Figures]
- Company Name: Samsung Biologics Co., Ltd. (207940)
- Record Date: July 29, 2025
- Share Transfer Suspension (Book Closure) Period: Not Applicable (Start and end dates are left blank)
- Reason for Setting: Determination of eligible shareholders for an upcoming Extraordinary General Meeting of Shareholders
- Other Material Terms:
- This measure is based on Article 354 of the Commercial Act and Article 14 of the corporate Articles of Incorporation.
- Following the enforcement of the “Act on Electronic Registration of Stocks, Bonds, etc.,” setting a formal book closure period is unnecessary for electronically registered shares; hence, the share transfer suspension period was omitted.
📈 2. [Expert Insight: What This Disclosure Means for Investors]
This filing represents a routine procedural announcement regarding corporate governance timelines rather than detailing adjustments to financial performance metrics or core operational fundamentals (Fundamental). Consequently, its direct implication on short-term market pricing remains limited.
For global market participants, the analytical value of this document lies in verifying the specific deadline and timeline to secure voting eligibility for the upcoming shareholder resolutions. Shareholders must hold the underlying stock as of the stated record date of July 29, 2025, to exercise their voting rights during the meeting. Given that the filing cross-references the “2025-05-22 Decision on Corporate Split,” it is confirmed that this registry targeting is a preliminary step geared toward voting on the restructuring plan. Since the traditional share transfer suspension period is bypassed under electronic registry regulations, investors should focus on tracking upcoming separate notices detailing the definitive date and agenda items of the scheduled general meeting.
📝 Editor’s Comment (by K-STOCK Editor)
Samsung Biologics has formalized July 29 as the definitive record date to lock in the voting block for its next Extraordinary General Meeting. While this administrative disclosure is a standard compliance routine, the linked historical filings indicate that this register alignment is a required step before voting on the proposed corporate split. Thanks to modern electronic registration laws, investors do not have to worry about trading freezes or liquidity pauses during this process. Long-term stakeholders intending to exercise corporate governance oversight should keep this late July timeline on their radar and await the upcoming detailed agenda descriptions.
📢 Disclaimer & Source Information
Source: This content has been structured and newly generated based on the official data submitted to the Financial Supervisory Service electronic disclosure system (DART).
Investment Risk Notice: This information is provided solely for informational and linguistic reference purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific stock. All investment decisions and financial responsibilities rest entirely with the investor.
Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.
🔥 Bulls vs Bears, drop your analysis in the comments!
